These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 28572861)

  • 1. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
    Wojdacz TK; Amarasinghe HE; Kadalayil L; Beattie A; Forster J; Blakemore SJ; Parker H; Bryant D; Larrayoz M; Clifford R; Robbe P; Davis ZA; Else M; Howard DR; Stamatopoulos B; Steele AJ; Rosenquist R; Collins A; Pettitt AR; Hillmen P; Plass C; Schuh A; Catovsky D; Oscier DG; Rose-Zerilli MJJ; Oakes CC; Strefford JC
    Blood Adv; 2019 Aug; 3(16):2474-2481. PubMed ID: 31434681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.
    Hanoun M; Eisele L; Suzuki M; Greally JM; Hüttmann A; Aydin S; Scholtysik R; Klein-Hitpass L; Dührsen U; Dürig J
    PLoS One; 2012; 7(3):e34347. PubMed ID: 22470559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Tsagiopoulou M; Moysiadis T; Bhoi S; Malousi A; Psomopoulos F; Mansouri L; Laidou S; Papazoglou D; Gounari M; Pasentsis K; Plevova K; Kuci-Emruli V; Duran-Ferrer M; Davis Z; Ek S; Rossi D; Gaidano G; Ritgen M; Oscier D; Stavroyianni N; Pospisilova S; Davi F; Ghia P; Hadzidimitriou A; Belessi C; Martin-Subero JI; Pott C; Rosenquist R; Stamatopoulos K
    Int J Cancer; 2019 Jun; 144(11):2695-2706. PubMed ID: 30447004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
    Cahill N; Bergh AC; Kanduri M; Göransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundström C; Rosén A; Rosenquist R
    Leukemia; 2013 Jan; 27(1):150-8. PubMed ID: 22922567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
    Huang D; Ovcharenko I
    BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact.
    Tong WG; Wierda WG; Lin E; Kuang SQ; Bekele BN; Estrov Z; Wei Y; Yang H; Keating MJ; Garcia-Manero G
    Epigenetics; 2010 Aug; 5(6):499-508. PubMed ID: 20484983
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Habashy DM; Eissa DS; Aboelez MM
    Turk J Haematol; 2018 Aug; 35(3):168-174. PubMed ID: 28884705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia.
    Ronchetti D; Tuana G; Rinaldi A; Agnelli L; Cutrona G; Mosca L; Fabris S; Matis S; Colombo M; Gentile M; Recchia AG; Kwee I; Bertoni F; Morabito F; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2014 Mar; 53(3):264-73. PubMed ID: 24347044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
    Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
    J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
    Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
    Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered DNA Methylation Profiles in
    Pacholewska A; Grimm C; Herling CD; Lienhard M; Königs A; Timmermann B; Altmüller J; Mücke O; Reinhardt HC; Plass C; Herwig R; Hallek M; Schweiger MR
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
    Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
    BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
    Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
    Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.